Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism

RTTNews | hace 462
Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism

(RTTNews) - Danish pharmaceutical company Ascendis Pharma A/S (ASND) announced that the United Kingdom's Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism

The MHRA has also granted YORVIPATH orphan drug status. YORVIPATH is a prodrug of parathyroid hormone (PTH 1-34) administered once daily.

MHRA approval of YORVIPATH is based on the same dossier submitted with Ascendis Pharma's Marketing Authorisation Application to the European Medicines Agency, which led to European Commission authorization of YORVIPATH in the European Union in November 2023.

The orphan status provides 10 years of market exclusivity in Great Britain with respect to similar medicinal products in the approved orphan indication of chronic adult hypoparathyroidism.

TransCon PTH is also in development for the treatment of adults with chronic hypoparathyroidism in the United States, Japan, and other countries.

read more
U.S. Pending Home Sales Unexpectedly Decrease In June

U.S. Pending Home Sales Unexpectedly Decrease In June

Pending home sales in the U.S. unexpectedly decreased in the month of June, according to a report released by the National Association of Realtors on Wednesday. NAR said its pending home sales index slid by 0.8 percent to 72.0 in June after jumping by 1.8 percent to 72.6 in May. Economists had expected pending home sales to rise by 0.2 percent.
RTTNews | hace 57 minutos
Bank Of Canada Leaves Interest Rates Unchanged For Third Straight Meeting

Bank Of Canada Leaves Interest Rates Unchanged For Third Straight Meeting

In a widely expected move, the Bank of Canada on Wednesday announced that it has once again decided to leave interest rates unchanged. The Bank of Canada said it decided to maintain its target for the overnight rate at 2.75 percent, with the Bank Rate at 3 percent and the deposit rate at 2.70 percent.
RTTNews | hace 1h 41min
U.S. GDP Rebounds In Q2 Amid Sharp Pullback By Imports

U.S. GDP Rebounds In Q2 Amid Sharp Pullback By Imports

The Commerce Department released a report on Wednesday showing the U.S. economy rebounded by more than expected in the second quarter of 2025. The report said real gross domestic product surged by 3.0 percent in the second quarter after falling by 0.5 percent in the first quarter. Economists had expected GDP to jump by 2.5 percent.
RTTNews | hace 1h 51min
U.S. Private Sector Job Growth Exceeds Estimates In July

U.S. Private Sector Job Growth Exceeds Estimates In July

Payroll processor ADP released a report on Wednesday showing private sector employment in the U.S. increased by more than expected in the month of July. The report said private sector employment jumped by 104,000 jobs in July after slipping by a revised 23,000 jobs in June.
RTTNews | hace 2h 6min
Eurozone Economy Fares Better Than Expected In Q2

Eurozone Economy Fares Better Than Expected In Q2

The euro area economy logged better-than-expected growth in the second quarter but the pace of expansion slowed markedly as the first quarter performance was inflated after U.S. importers frontloaded their orders to reduce the cost burden of higher tariffs. Gross domestic product grew 0.1 percent sequentially, after rising 0.6 percent in the first quarter, preliminary flash estimate from Eurostat.
RTTNews | hace 2h 39min